(SILVER SPRING, Md.) -- The U.S. Food and Drug Administration on Friday approved a drug that it says is more effective than others when it comes to treating high blood pressure.
The FDA approved Edarbi tablets for treatment of hypertension in adults. Officials say data from clinical studies shows that Edarbi has proven to be more effective in lowering 24-hour blood pressure as compared to FDA-approved hypertension drugs, Diovan and Benicar.
"High blood pressure is often called the 'silent killer' because it usually has no symptoms until it causes damage to the body," said Norman Stockbridge, M.D., Ph.D., of the FDA's Center for Drug Evaluation and Research. "High blood pressure remains inadequately controlled in many people diagnosed with the condition, so having a variety of treatment options is important."
In a release, the FDA described Edarbi as being an angiotensin II receptor blocker that lowers blood pressure by blocking the action of angiotensin II, a vasopressor hormone.
Copyright 2011 ABC News Radio